LLY

965.93

+4.72%↑

JNJ

187.89

+0.86%↑

UNH

321.52

-0.8%↓

NVS

127.05

+0.61%↑

ABT

125.76

-0.34%↓

LLY

965.93

+4.72%↑

JNJ

187.89

+0.86%↑

UNH

321.52

-0.8%↓

NVS

127.05

+0.61%↑

ABT

125.76

-0.34%↓

LLY

965.93

+4.72%↑

JNJ

187.89

+0.86%↑

UNH

321.52

-0.8%↓

NVS

127.05

+0.61%↑

ABT

125.76

-0.34%↓

LLY

965.93

+4.72%↑

JNJ

187.89

+0.86%↑

UNH

321.52

-0.8%↓

NVS

127.05

+0.61%↑

ABT

125.76

-0.34%↓

LLY

965.93

+4.72%↑

JNJ

187.89

+0.86%↑

UNH

321.52

-0.8%↓

NVS

127.05

+0.61%↑

ABT

125.76

-0.34%↓

Search

AcelRx Pharmaceuticals Inc

Suletud

0

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

Max

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+532.91% upside

AcelRx Pharmaceuticals Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

10. nov 2025, 22:17 UTC

Tulu

Commonwealth Bank Posts Flat 1Q Profit Despite Margin Pressure -- Update

10. nov 2025, 21:48 UTC

Tulu

Commonwealth Bank Posts Flat 1Q Profit Despite Margin Pressure

10. nov 2025, 23:44 UTC

Market Talk

Gold Edges Higher on Signs of Possible End to U.S. Govt Shutdown -- Market Talk

10. nov 2025, 23:43 UTC

Market Talk

Nikkei May Rise on Weaker Yen, Earnings Hopes -- Market Talk

10. nov 2025, 22:20 UTC

Omandamised, ülevõtmised, äriostud

Paramount Stock Climbs as Forecast Beats Estimates -- Barrons.com

10. nov 2025, 21:50 UTC

Market Talk
Tulu

Basic Materials Roundup: Market Talk

10. nov 2025, 21:50 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Health Care Roundup: Market Talk

10. nov 2025, 21:49 UTC

Omandamised, ülevõtmised, äriostud

Paramount Stock Climbs as Forecast Beats Estimates -- Barrons.com

10. nov 2025, 21:45 UTC

Tulu

PepsiCo and 3 Other Defensive Stocks to Ride Out a Vulnerable Market -- Barrons.com

10. nov 2025, 21:40 UTC

Tulu

Friedman Industries 2Q EPS 32c >FRD

10. nov 2025, 21:18 UTC

Tulu

Occidental Petroleum 3Q Adj EPS 64c >OXY

10. nov 2025, 21:17 UTC

Tulu

Occidental Petroleum 3Q EPS 65c >OXY

10. nov 2025, 21:17 UTC

Tulu

Occidental Petroleum 3Q Rev $6.72B >OXY

10. nov 2025, 21:16 UTC

Tulu

Occidental Petroleum 3Q EPS 65c >OXY

10. nov 2025, 21:16 UTC

Tulu

Occidental Petroleum 3Q Adj EPS 64c >OXY

10. nov 2025, 20:30 UTC

Market Talk

Expected End to U.S. Government Shutdown Helps Lift Crude -- Market Talk

10. nov 2025, 20:24 UTC

Market Talk

Hopes For New Government Data Lift Gold -- Market Talk

10. nov 2025, 20:08 UTC

Market Talk

U.S. Natural Gas Settles Higher As Colder Weather Arrives -- Market Talk

10. nov 2025, 19:49 UTC

Market Talk

Mexican Industrial Production Seen Soft in September -- Market Talk

10. nov 2025, 19:43 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Paramount Earnings Come Amid Warner Bros Merger Reports -- Barrons.com

10. nov 2025, 19:16 UTC

Tulu

Charles Schwab's CEO Is Worried About Prediction Markets. What He Told Thousands of Financial Advisors. -- Barrons.com

10. nov 2025, 17:58 UTC

Omandamised, ülevõtmised, äriostud

Eli Lilly Stock on Pace for a New High. The Zepbound Maker Just Got a Big Upgrade. -- Barrons.com

10. nov 2025, 17:56 UTC

Market Talk

Oil Futures Edge Up in Rangebound Trade -- Market Talk

10. nov 2025, 17:32 UTC

Tulu

Barrick Looking to Reset Safety Culture Following Fatalities -- Interview

10. nov 2025, 17:30 UTC

Tulu

Barrick Continues Efforts to Free Workers Jailed in Mali -- Interview

10. nov 2025, 17:20 UTC

Market Talk
Tulu

Basic Materials Roundup: Market Talk

10. nov 2025, 17:20 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Health Care Roundup: Market Talk

10. nov 2025, 17:00 UTC

Tulu

Barrick Looks to Get Handle On North American Operations, Find Growth -- Interview

10. nov 2025, 17:00 UTC

Tulu

Barrick Expects Strong Cash Flows Ahead With Commodity Prices at Current Levels, CFO Says in Interview

10. nov 2025, 17:00 UTC

Tulu

Barrick Conducting Bottom-Up Review of Nevada Ops, Looking for Growth Opportunities

Võrdlus sarnastega

Hinnamuutus

AcelRx Pharmaceuticals Inc Prognoos

Hinnasiht

By TipRanks

532.91% tõus

12 kuu keskmine prognoos

Keskmine 5 USD  532.91%

Kõrge 5 USD

Madal 5 USD

Põhineb 1 Wall Streeti analüütiku instrumendi AcelRx Pharmaceuticals Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

1

Osta

0

Hoia

0

Müü

Finantsandmed

$

help-icon Live chat